Cargando…
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol
INTRODUCTION: The combination of biomarkers and drugs is the subject of growing interest both from regulators, physicians and companies. This study protocol of a systematic review is aimed to describe available literature evidences about the cost-effectiveness, cost-utility or net-monetary benefit o...
Autores principales: | Mucherino, Sara, Lorenzoni, Valentina, Orlando, Valentina, Triulzi, Isotta, Del Re, Marzia, Capuano, Annalisa, Danesi, Romano, Turchetti, Giuseppe, Menditto, Enrica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438832/ https://www.ncbi.nlm.nih.gov/pubmed/34497081 http://dx.doi.org/10.1136/bmjopen-2020-048141 |
Ejemplares similares
-
Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: the Italian National Health System perspective
por: Lorenzoni, Valentina, et al.
Publicado: (2018) -
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks
por: Rosaria, Talarico, et al.
Publicado: (2020) -
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives
por: Cannizzo, Sara, et al.
Publicado: (2018) -
Correction to: RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks
por: Talarico, Rosaria, et al.
Publicado: (2021) -
Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study
por: Orlando, Valentina, et al.
Publicado: (2020)